Canagliflozin [canagliflozin]
topical
45
- Terms
-
canagliflozinum hemihydricum
hemihydrát canagliflozinu
hemihydrát kanagliflozinu
Invokana
kanagliflozin
-
1-(Glucopyranosyl)-4-methyl-3-(5-(4-fluorophenyl)-2-thienylmethyl)benzene - T777973
Canagliflozin Hemihydrate
Canagliflozin, Anhydrous
Invokana
Persistent link
https://www.medvik.cz/link/D000068896
Definition
A glucoside-derived SODIUM-GLUCOSE TRANSPORTER 2 inhibitor that stimulates urinary excretion of glucose by suppressing renal glucose reabsorption. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES.
- DUI
- D000068896 MeSH Browser
- CUI
- M0550188
- History note
- 2016 (2014)
- Public note
- 2016; CANAGLIFLOZIN was indexed under GLUCOSIDES and THIOPHENES 2014-2015
Allowable subheadings
- AD
- administration & dosage 19
- AE
- adverse effects 8
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry 1
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism 1
- PK
- pharmacokinetics 5
- PD
- pharmacology 17
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 32
- TO
- toxicity
- UR
- urine
...
Occurrences in Medvik records
D
Chemicals and Drugs
D02.886.778.440
Morantel
D02.886.778.840
Ticrynafen
D03.383.903.440
Morantel
D03.383.903.840
Ticrynafen